Mcl‐1 and Bcl‐xL cooperatively maintain integrity of hepatocytes in developing and adult murine liver

Anti‐apoptotic members of the Bcl‐2 family, including Bcl‐2, Bcl‐xL, Mcl‐1, Bcl‐w and Bfl‐1, inhibit the mitochondrial pathway of apoptosis. Bcl‐xL and Mcl‐1 are constitutively expressed in the liver. Although previous research established Bcl‐xL as a critical apoptosis antagonist in differentiated hepatocytes, the significance of Mcl‐1 in the liver, especially in conjunction with Bcl‐xL, has not been clear. To examine this question, we generated hepatocyte‐specific Mcl‐1–deficient mice by crossing mcl‐1flox/flox mice and AlbCre mice and further crossed them with bcl‐xflox/flox mice, giving Mcl‐1/Bcl‐xL–deficient mice. The mcl‐1flox/flox AlbCre mice showed spontaneous apoptosis of hepatocytes after birth, as evidenced by elevated levels of serum alanine aminotransferase (ALT) and caspase‐3/7 activity and an increased number of terminal deoxynucleotidyl transferase‐mediated 2′‐deoxyuridine 5′‐triphosphate nick‐end labeling (TUNEL)‐positive cells in the liver; these phenotypes were very close to those previously found in hepatocyte‐specific Bcl‐xL–deficient mice. Although mcl‐1flox/+ AlbCre mice did not display apoptosis, their susceptibility to Fas‐mediated liver injury significantly increased. Further crossing of Mcl‐1 mice with Bcl‐xL mice showed that bcl‐xflox/+ mcl‐1flox/+ AlbCre mice also showed spontaneous hepatocyte apoptosis similar to Bcl‐xL–deficient or Mcl‐1–deficient mice. In contrast, bcl‐xflox/flox mcl‐1flox/+ AlbCre, bcl‐xflox/+ mcl‐1flox/flox AlbCre, and bcl‐xflox/flox mcl‐1flox/flox AlbCre mice displayed a decreased number of hepatocytes and a reduced volume of the liver on day 18.5 of embryogenesis and rapidly died within 1 day after birth, developing hepatic failure evidenced by increased levels of blood ammonia and bilirubin. Conclusion: Mcl‐1 is critical for blocking apoptosis in adult liver and, in the absence of Bcl‐xL, is essential for normal liver development. Mcl‐1 and Bcl‐xL are two major anti‐apoptotic Bcl‐2 family proteins expressed in the liver and cooperatively control hepatic integrity during liver development and in adult liver homeostasis in a gene dose‐dependent manner. (HEPATOLOGY 2009.)

[1]  Marcus Schuchmann,et al.  Knockout of myeloid cell leukemia‐1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes , 2009, Hepatology.

[2]  J. Bruix,et al.  Molecular targeted therapies in hepatocellular carcinoma , 2008, Hepatology.

[3]  G. Gores,et al.  Cellular and molecular mechanisms of liver injury. , 2008, Gastroenterology.

[4]  A. Strasser,et al.  The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.

[5]  L. Boscá,et al.  Protection against Fas‐induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes , 2007, Hepatology.

[6]  You-Wen He,et al.  The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages. , 2007, Blood.

[7]  S. Wilhelm,et al.  Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. , 2006, Cancer research.

[8]  P. Galle,et al.  Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction , 2006, BMC Cancer.

[9]  G. Gores,et al.  Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas‐induced murine liver injury by altering Bcl‐2 proteins , 2006, Hepatology.

[10]  Xiao-Ming Yin Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. , 2006, Gene.

[11]  M. Peck-Radosavljevic,et al.  Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. , 2006, Journal of hepatology.

[12]  P. Galle,et al.  Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma. , 2006, International journal of oncology.

[13]  K. Kaestner The making of the liver: developmental competence in foregut endoderm and induction of the hepatogenic program. , 2005, Cell cycle.

[14]  Takahiro Suzuki,et al.  Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. , 2004, Gastroenterology.

[15]  D. Zink,et al.  Hepatocyte growth factor induces Mcl‐1 in primary human hepatocytes and inhibits CD95‐mediated apoptosis via Akt , 2004, Hepatology.

[16]  Y. Tsujimoto Cell death: regulation by the Bcl‐2 protein family , 2006 .

[17]  T. Takehara,et al.  Suppression of Bcl-xL deamidation in human hepatocellular carcinomas. , 2003, Cancer research.

[18]  K. Schulze-Osthoff,et al.  Many cuts to ruin: a comprehensive update of caspase substrates , 2003, Cell Death and Differentiation.

[19]  J. Slack,et al.  Differentiated properties of hepatocytes induced from pancreatic cells , 2002, Hepatology.

[20]  S. Friedman,et al.  Expression and role of Bcl‐xL in human hepatocellular carcinomas , 2001, Hepatology.

[21]  S. Korsmeyer,et al.  Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.

[22]  L. Hennighausen,et al.  Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. , 2000, Development.

[23]  K. Roth,et al.  Mcl-1 deficiency results in peri-implantation embryonic lethality. , 2000, Genes & development.

[24]  N. Hayashi,et al.  Interleukin 1beta protects mice from Fas-mediated hepatocyte apoptosis and death. , 1999, Gastroenterology.

[25]  S. Korsmeyer,et al.  Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis , 1999, Nature.

[26]  G. Gores,et al.  Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. , 1999, The Journal of clinical investigation.

[27]  K. Nakayama,et al.  Accelerated Neutrophil Apoptosis in Mice Lacking A1-a, a Subtype of the bcl-2–related A1 Gene , 1998, The Journal of experimental medicine.

[28]  C. Print,et al.  Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Peter,et al.  Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.

[30]  M. Skinner,et al.  Testicular degeneration in Bclw-deficient mice , 1998, Nature Genetics.

[31]  al. et,et al.  Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice , 1995, Science.

[32]  D. Loh,et al.  Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Korsmeyer,et al.  Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair , 1993, Cell.

[34]  K. Zaret,et al.  Hepatocyte differentiation initiates during endodermal-mesenchymal interactions prior to liver formation. , 1991, Development.